IBDEI0JE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8502,1,2,0)
 ;;=2^17312
 ;;^UTILITY(U,$J,358.3,8502,1,3,0)
 ;;=3^MOHS H/N/HF/G,Ea Addl Stage
 ;;^UTILITY(U,$J,358.3,8503,0)
 ;;=17313^^66^560^3^^^^1
 ;;^UTILITY(U,$J,358.3,8503,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8503,1,2,0)
 ;;=2^17313
 ;;^UTILITY(U,$J,358.3,8503,1,3,0)
 ;;=3^MOHS 1 Stage T/A/L
 ;;^UTILITY(U,$J,358.3,8504,0)
 ;;=17314^^66^560^4^^^^1
 ;;^UTILITY(U,$J,358.3,8504,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8504,1,2,0)
 ;;=2^17314
 ;;^UTILITY(U,$J,358.3,8504,1,3,0)
 ;;=3^MOHS T/A/L,Ea Addl Stage
 ;;^UTILITY(U,$J,358.3,8505,0)
 ;;=17315^^66^560^5^^^^1
 ;;^UTILITY(U,$J,358.3,8505,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8505,1,2,0)
 ;;=2^17315
 ;;^UTILITY(U,$J,358.3,8505,1,3,0)
 ;;=3^MOHS Surg Addl Block
 ;;^UTILITY(U,$J,358.3,8506,0)
 ;;=96372^^66^561^12^^^^1
 ;;^UTILITY(U,$J,358.3,8506,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8506,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,8506,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,8507,0)
 ;;=96406^^66^561^2^^^^1
 ;;^UTILITY(U,$J,358.3,8507,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8507,1,2,0)
 ;;=2^96406
 ;;^UTILITY(U,$J,358.3,8507,1,3,0)
 ;;=3^Chemo Intralesional > 7
 ;;^UTILITY(U,$J,358.3,8508,0)
 ;;=96405^^66^561^1^^^^1
 ;;^UTILITY(U,$J,358.3,8508,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8508,1,2,0)
 ;;=2^96405
 ;;^UTILITY(U,$J,358.3,8508,1,3,0)
 ;;=3^Chemo Intralesional Up to 7
 ;;^UTILITY(U,$J,358.3,8509,0)
 ;;=11901^^66^561^9^^^^1
 ;;^UTILITY(U,$J,358.3,8509,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8509,1,2,0)
 ;;=2^11901
 ;;^UTILITY(U,$J,358.3,8509,1,3,0)
 ;;=3^Skin Lesion Injection,Addl Lesions
 ;;^UTILITY(U,$J,358.3,8510,0)
 ;;=11900^^66^561^10^^^^1
 ;;^UTILITY(U,$J,358.3,8510,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8510,1,2,0)
 ;;=2^11900
 ;;^UTILITY(U,$J,358.3,8510,1,3,0)
 ;;=3^Skin Lesion Injection,Up to 7 Lesions
 ;;^UTILITY(U,$J,358.3,8511,0)
 ;;=Q2026^^66^561^7^^^^1
 ;;^UTILITY(U,$J,358.3,8511,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8511,1,2,0)
 ;;=2^Q2026
 ;;^UTILITY(U,$J,358.3,8511,1,3,0)
 ;;=3^Radiesse Inj 0.1 ml
 ;;^UTILITY(U,$J,358.3,8512,0)
 ;;=Q2028^^66^561^8^^^^1
 ;;^UTILITY(U,$J,358.3,8512,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8512,1,2,0)
 ;;=2^Q2028
 ;;^UTILITY(U,$J,358.3,8512,1,3,0)
 ;;=3^Sculptra Inj 0.5mg
 ;;^UTILITY(U,$J,358.3,8513,0)
 ;;=G0429^^66^561^3^^^^1
 ;;^UTILITY(U,$J,358.3,8513,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8513,1,2,0)
 ;;=2^G0429
 ;;^UTILITY(U,$J,358.3,8513,1,3,0)
 ;;=3^Dermal Filler Inj Px/Supply
 ;;^UTILITY(U,$J,358.3,8514,0)
 ;;=J0135^^66^561^4^^^^1
 ;;^UTILITY(U,$J,358.3,8514,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8514,1,2,0)
 ;;=2^J0135
 ;;^UTILITY(U,$J,358.3,8514,1,3,0)
 ;;=3^Humira (Adalimumab) 20mg
 ;;^UTILITY(U,$J,358.3,8515,0)
 ;;=J3301^^66^561^5^^^^1
 ;;^UTILITY(U,$J,358.3,8515,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8515,1,2,0)
 ;;=2^J3301
 ;;^UTILITY(U,$J,358.3,8515,1,3,0)
 ;;=3^Kenalog (Triamcinolone Acetonide) 10mg
 ;;^UTILITY(U,$J,358.3,8516,0)
 ;;=J7308^^66^561^6^^^^1
 ;;^UTILITY(U,$J,358.3,8516,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8516,1,2,0)
 ;;=2^J7308
 ;;^UTILITY(U,$J,358.3,8516,1,3,0)
 ;;=3^Levulan Kerasticks (Aminolevulinic Acid Hcl) 20%
 ;;^UTILITY(U,$J,358.3,8517,0)
 ;;=J3357^^66^561^11^^^^1
 ;;^UTILITY(U,$J,358.3,8517,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8517,1,2,0)
 ;;=2^J3357
